These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35988447)

  • 1. Mitochondrial and redox modifications in early stages of Huntington's disease.
    Lopes C; Ferreira IL; Maranga C; Beatriz M; Mota SI; Sereno J; Castelhano J; Abrunhosa A; Oliveira F; De Rosa M; Hayden M; Laço MN; Januário C; Castelo Branco M; Rego AC
    Redox Biol; 2022 Oct; 56():102424. PubMed ID: 35988447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative metabolism and Ca
    Hamilton J; Brustovetsky T; Brustovetsky N
    Neurochem Int; 2017 Oct; 109():24-33. PubMed ID: 28062223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative metabolism in YAC128 mouse model of Huntington's disease.
    Hamilton J; Pellman JJ; Brustovetsky T; Harris RA; Brustovetsky N
    Hum Mol Genet; 2015 Sep; 24(17):4862-78. PubMed ID: 26041817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive Mitochondrial Dysfunction of Striatal Synapses in R6/2 Mouse Model of Huntington's Disease.
    Petersen MH; Willert CW; Andersen JV; Madsen M; Waagepetersen HS; Skotte NH; Nørremølle A
    J Huntingtons Dis; 2022; 11(2):121-140. PubMed ID: 35311711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca(2+) handling in isolated brain mitochondria and cultured neurons derived from the YAC128 mouse model of Huntington's disease.
    Pellman JJ; Hamilton J; Brustovetsky T; Brustovetsky N
    J Neurochem; 2015 Aug; 134(4):652-67. PubMed ID: 25963273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial fission in Huntington's disease mouse striatum disrupts ER-mitochondria contacts leading to disturbances in Ca
    Cherubini M; Lopez-Molina L; Gines S
    Neurobiol Dis; 2020 Mar; 136():104741. PubMed ID: 31931142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered mitochondrial Ca
    Yoo H; Park H
    Biochem Biophys Res Commun; 2024 Jul; 716():150010. PubMed ID: 38704892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington's Disease Models.
    Naia L; Rosenstock TR; Oliveira AM; Oliveira-Sousa SI; Caldeira GL; Carmo C; Laço MN; Hayden MR; Oliveira CR; Rego AC
    Mol Neurobiol; 2017 Sep; 54(7):5385-5399. PubMed ID: 27590140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Energy Metabolism and Mitochondrial Superoxide Anion Production in Pre-symptomatic Striatal Neurons Derived from Human-Induced Pluripotent Stem Cells Expressing Mutant Huntingtin.
    Hamilton J; Brustovetsky T; Sridhar A; Pan Y; Cummins TR; Meyer JS; Brustovetsky N
    Mol Neurobiol; 2020 Feb; 57(2):668-684. PubMed ID: 31435904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease.
    Graham RK; Pouladi MA; Joshi P; Lu G; Deng Y; Wu NP; Figueroa BE; Metzler M; André VM; Slow EJ; Raymond L; Friedlander R; Levine MS; Leavitt BR; Hayden MR
    J Neurosci; 2009 Feb; 29(7):2193-204. PubMed ID: 19228972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Sigma-1 Receptor Mediates Pridopidine Rescue of Mitochondrial Function in Huntington Disease Models.
    Naia L; Ly P; Mota SI; Lopes C; Maranga C; Coelho P; Gershoni-Emek N; Ankarcrona M; Geva M; Hayden MR; Rego AC
    Neurotherapeutics; 2021 Apr; 18(2):1017-1038. PubMed ID: 33797036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in STriatal-Enriched protein tyrosine Phosphatase expression, activation, and downstream signaling in early and late stages of the YAC128 Huntington's disease mouse model.
    Gladding CM; Fan J; Zhang LY; Wang L; Xu J; Li EH; Lombroso PJ; Raymond LA
    J Neurochem; 2014 Jul; 130(1):145-59. PubMed ID: 24588402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired Replenishment of Cortico-Striatal Synaptic Glutamate in Huntington's Disease Mouse Model.
    Buren C; Tu G; Raymond LA
    J Huntingtons Dis; 2020; 9(2):149-161. PubMed ID: 32310183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
    Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
    Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Store-Operated Calcium Entry Leads to Striatal Synaptic Loss in a Huntington's Disease Mouse Model.
    Wu J; Ryskamp DA; Liang X; Egorova P; Zakharova O; Hung G; Bezprozvanny I
    J Neurosci; 2016 Jan; 36(1):125-41. PubMed ID: 26740655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural stem cells derived from the developing forebrain of YAC128 mice exhibit pathological features of Huntington's disease.
    Li E; Park HR; Hong CP; Kim Y; Choi J; Lee S; Park HJ; Lee B; Kim TA; Kim SJ; Kim HS; Song J
    Cell Prolif; 2020 Oct; 53(10):e12893. PubMed ID: 32865873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early TNF-Dependent Regulation of Excitatory and Inhibitory Synapses on Striatal Direct Pathway Medium Spiny Neurons in the YAC128 Mouse Model of Huntington's Disease.
    Chambon J; Komal P; Lewitus GM; Kemp GM; Valade S; Adaïdi H; Al Bistami N; Stellwagen D
    J Neurosci; 2023 Jan; 43(4):672-680. PubMed ID: 36517241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin.
    Damiano M; Diguet E; Malgorn C; D'Aurelio M; Galvan L; Petit F; Benhaim L; Guillermier M; Houitte D; Dufour N; Hantraye P; Canals JM; Alberch J; Delzescaux T; Déglon N; Beal MF; Brouillet E
    Hum Mol Genet; 2013 Oct; 22(19):3869-82. PubMed ID: 23720495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel proteomic changes in brain mitochondria provide insights into mitochondrial dysfunction in mouse models of Huntington's disease.
    Agrawal S; Fox JH
    Mitochondrion; 2019 Jul; 47():318-329. PubMed ID: 30902619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative metabolism and Ca2+ handling in isolated brain mitochondria and striatal neurons from R6/2 mice, a model of Huntington's disease.
    Hamilton J; Pellman JJ; Brustovetsky T; Harris RA; Brustovetsky N
    Hum Mol Genet; 2016 Jul; 25(13):2762-2775. PubMed ID: 27131346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.